/

Outpace Bio

Develops AI-designed cell therapies for treating solid tumors.

BiotechnologyPharmaceuticals outpacebio.com ↗

Company facts

Founded: 2020
Employees: 72
Headquarters: United States
Type: Private
Funding: Series B · $144M · 2024